Annual total expenses:
$7.18B-$3.81B(-34.68%)Summary
- As of today (May 21, 2025), MRNA annual total expenses is $7.18 billion, with the most recent change of -$3.81 billion (-34.68%) on December 31, 2024.
- During the last 3 years, MRNA annual total expenses has risen by +$2.74 billion (+61.73%).
- MRNA annual total expenses is now -34.68% below its all-time high of $10.99 billion, reached on December 31, 2023.
Performance
MRNA Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$1.16B-$1.04B(-47.46%)Summary
- As of today (May 21, 2025), MRNA quarterly total expenses is $1.16 billion, with the most recent change of -$1.04 billion (-47.46%) on March 31, 2025.
- Over the past year, MRNA quarterly total expenses has dropped by -$276.00 million (-19.26%).
- MRNA quarterly total expenses is now -69.54% below its all-time high of $3.80 billion, reached on September 30, 2023.
Performance
MRNA Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
MRNA Total expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.7% | -19.3% |
| 3 y3 years | +61.7% | -32.5% |
| 5 y5 years | +1108.9% | +757.0% |
MRNA Total expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -34.7% | +61.7% | -69.5% | at low |
| 5 y | 5-year | -34.7% | +1108.9% | -69.5% | +757.0% |
| alltime | all time | -34.7% | >+9999.0% | -69.5% | >+9999.0% |
MRNA Total expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.16B(-47.5%) |
| Dec 2024 | $7.18B(-34.7%) | $2.20B(+14.4%) |
| Sep 2024 | - | $1.93B(+21.5%) |
| Jun 2024 | - | $1.58B(+10.5%) |
| Mar 2024 | - | $1.43B(-48.9%) |
| Dec 2023 | $10.99B(+16.3%) | $2.81B(-26.1%) |
| Sep 2023 | - | $3.80B(+74.0%) |
| Jun 2023 | - | $2.18B(-1.0%) |
| Mar 2023 | - | $2.20B(-38.2%) |
| Dec 2022 | $9.46B(+113.0%) | $3.57B(+73.8%) |
| Sep 2022 | - | $2.05B(-3.1%) |
| Jun 2022 | - | $2.12B(+23.7%) |
| Mar 2022 | - | $1.71B(+11.3%) |
| Dec 2021 | $4.44B(+328.2%) | $1.54B(+21.1%) |
| Sep 2021 | - | $1.27B(+10.2%) |
| Jun 2021 | - | $1.15B(+141.7%) |
| Mar 2021 | - | $477.00M(-5.4%) |
| Dec 2020 | $1.04B(+74.6%) | $504.00M(+104.0%) |
| Sep 2020 | - | $247.00M(+63.6%) |
| Jun 2020 | - | $151.00M(+11.9%) |
| Mar 2020 | - | $135.00M(-3.8%) |
| Dec 2019 | $594.00M(+10.9%) | $140.40M(-2.6%) |
| Sep 2019 | - | $144.10M(-6.3%) |
| Jun 2019 | - | $153.74M(-1.3%) |
| Mar 2019 | - | $155.76M(-16.2%) |
| Dec 2018 | $535.78M(+20.0%) | $185.85M(+51.7%) |
| Sep 2018 | - | $122.48M(-0.3%) |
| Jun 2018 | - | $122.85M(+17.2%) |
| Mar 2018 | - | $104.86M(-19.5%) |
| Dec 2017 | $446.33M(+37.2%) | $130.24M(>+9900.0%) |
| Sep 2017 | - | $1.04M(+9.2%) |
| Jun 2017 | - | $948.90K(-1.9%) |
| Mar 2017 | - | $967.30K(+131.7%) |
| Dec 2016 | $325.31M(+6867.4%) | - |
| Dec 2016 | - | $417.40K(+327.2%) |
| Sep 2016 | - | $97.70K(-23.9%) |
| Jun 2016 | - | $128.40K(+12.4%) |
| Mar 2016 | - | $114.20K(-86.1%) |
| Dec 2015 | $4.67M(+16.1%) | $820.00K(-26.3%) |
| Sep 2015 | - | $1.11M(-21.8%) |
| Jun 2015 | - | $1.42M(+8.1%) |
| Mar 2015 | - | $1.31M(+11.5%) |
| Dec 2014 | $4.02M(+62.1%) | $1.18M(-26.6%) |
| Sep 2014 | - | $1.61M(+139.5%) |
| Jun 2014 | - | $671.00K(+19.2%) |
| Mar 2014 | - | $563.00K(-42.4%) |
| Dec 2013 | $2.48M(-76.2%) | $977.00K(+44.5%) |
| Sep 2013 | - | $676.00K(+34.9%) |
| Jun 2013 | - | $501.00K(+53.7%) |
| Mar 2013 | - | $326.00K(-87.5%) |
| Dec 2012 | $10.42M(-47.4%) | $2.61M(+93.0%) |
| Sep 2012 | - | $1.35M(-38.2%) |
| Jun 2012 | - | $2.19M(-48.9%) |
| Mar 2012 | - | $4.28M(+1.2%) |
| Dec 2011 | $19.81M(-30.4%) | $4.23M(-12.1%) |
| Sep 2011 | - | $4.81M(-12.9%) |
| Jun 2011 | - | $5.52M(+5.1%) |
| Mar 2011 | - | $5.25M(+10.2%) |
| Dec 2010 | $28.46M(+14.0%) | $4.76M(-58.4%) |
| Sep 2010 | - | $11.46M(+88.3%) |
| Jun 2010 | - | $6.08M(-1.2%) |
| Mar 2010 | - | $6.16M(+14.9%) |
| Dec 2009 | $24.97M | $5.36M(-21.2%) |
| Sep 2009 | - | $6.80M(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | $6.59M(+5.9%) |
| Mar 2009 | - | $6.22M(-49.1%) |
| Dec 2008 | $53.29M(-26.7%) | $12.24M(+20.2%) |
| Sep 2008 | - | $10.18M(-32.0%) |
| Jun 2008 | - | $14.98M(-5.7%) |
| Mar 2008 | - | $15.89M(-15.0%) |
| Dec 2007 | $72.67M(+25.7%) | $18.70M(-0.9%) |
| Sep 2007 | - | $18.86M(+5.5%) |
| Jun 2007 | - | $17.89M(+3.9%) |
| Mar 2007 | - | $17.22M(+8.2%) |
| Dec 2006 | $57.81M(+40.1%) | $15.91M(+14.1%) |
| Sep 2006 | - | $13.94M(+11.0%) |
| Jun 2006 | - | $12.56M(-18.3%) |
| Mar 2006 | - | $15.39M(+42.7%) |
| Dec 2005 | $41.25M(+36.0%) | $10.78M(+3.0%) |
| Sep 2005 | - | $10.46M(+1.7%) |
| Jun 2005 | - | $10.29M(+5.9%) |
| Mar 2005 | - | $9.72M(+31.8%) |
| Dec 2004 | $30.34M(+18.3%) | $7.37M(-4.6%) |
| Sep 2004 | - | $7.73M(+3.3%) |
| Jun 2004 | - | $7.49M(-3.4%) |
| Mar 2004 | - | $7.75M(+13.3%) |
| Dec 2003 | $25.65M(+17.1%) | $6.84M(+1.5%) |
| Sep 2003 | - | $6.74M(-2.6%) |
| Jun 2003 | - | $6.92M(+34.4%) |
| Mar 2003 | - | $5.15M(-24.9%) |
| Dec 2002 | $21.91M(+80.2%) | $6.86M(+25.5%) |
| Sep 2002 | - | $5.46M(+4.9%) |
| Jun 2002 | - | $5.21M(+18.7%) |
| Mar 2002 | - | $4.39M(+28.4%) |
| Dec 2001 | $12.16M(-16.0%) | $3.42M(+26.3%) |
| Sep 2001 | - | $2.70M(-7.3%) |
| Jun 2001 | - | $2.92M(-6.5%) |
| Mar 2001 | - | $3.12M(-37.3%) |
| Dec 2000 | $14.48M(+3.4%) | $4.98M(+65.5%) |
| Sep 2000 | - | $3.01M(-6.9%) |
| Jun 2000 | - | $3.23M(-0.8%) |
| Mar 2000 | - | $3.26M(-34.9%) |
| Dec 1999 | $14.00M(+33.3%) | $5.00M(+66.7%) |
| Sep 1999 | - | $3.00M(+7.1%) |
| Jun 1999 | - | $2.80M(-26.3%) |
| Mar 1999 | - | $3.80M(+5.6%) |
| Dec 1998 | $10.50M(+4.0%) | $3.60M(+50.0%) |
| Sep 1998 | - | $2.40M(-20.0%) |
| Jun 1998 | - | $3.00M(+30.4%) |
| Mar 1998 | - | $2.30M(-34.3%) |
| Dec 1997 | $10.10M(+320.8%) | $3.50M(+29.6%) |
| Sep 1997 | - | $2.70M(+12.5%) |
| Jun 1997 | - | $2.40M(+60.0%) |
| Mar 1997 | - | $1.50M(+36.4%) |
| Dec 1996 | $2.40M(-40.0%) | - |
| Sep 1996 | - | $1.10M(-8.3%) |
| Jun 1996 | $4.00M(+33.3%) | $1.20M(+33.3%) |
| Mar 1996 | - | $900.00K(-10.0%) |
| Dec 1995 | - | $1.00M(+11.1%) |
| Sep 1995 | - | $900.00K(-10.0%) |
| Jun 1995 | $3.00M(+57.9%) | $1.00M(+42.9%) |
| Mar 1995 | - | $700.00K(0.0%) |
| Dec 1994 | - | $700.00K(+16.7%) |
| Sep 1994 | - | $600.00K(0.0%) |
| Jun 1994 | $1.90M | $600.00K(0.0%) |
| Mar 1994 | - | $600.00K(+100.0%) |
| Dec 1993 | - | $300.00K(-25.0%) |
| Sep 1993 | - | $400.00K |
FAQ
- What is Moderna annual total expenses?
- What is the all time high annual total expenses for Moderna?
- What is Moderna annual total expenses year-on-year change?
- What is Moderna quarterly total expenses?
- What is the all time high quarterly total expenses for Moderna?
- What is Moderna quarterly total expenses year-on-year change?
What is Moderna annual total expenses?
The current annual total expenses of MRNA is $7.18B
What is the all time high annual total expenses for Moderna?
Moderna all-time high annual total expenses is $10.99B
What is Moderna annual total expenses year-on-year change?
Over the past year, MRNA annual total expenses has changed by -$3.81B (-34.68%)
What is Moderna quarterly total expenses?
The current quarterly total expenses of MRNA is $1.16B
What is the all time high quarterly total expenses for Moderna?
Moderna all-time high quarterly total expenses is $3.80B
What is Moderna quarterly total expenses year-on-year change?
Over the past year, MRNA quarterly total expenses has changed by -$276.00M (-19.26%)